Mirum Pharmaceuticals Appoints Saira Ramasastry to Board of Directors - businesswire.com -BoardProspects

Mirum Pharmaceuticals Appoints Saira Ramasastry to Board of Directors

businesswire.com Jun 7 2022 BoardMoves

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced the appointment of Saira Ramasastry to the Company’s board of directors and as a member of the audit committee where she will bring to bear her more than 20 years of financial leadership...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Accomplished Lawyer Returns to Fulbright's Houston Office also published in businesswire.com
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- BMC’s Independent, Experienced Board Overseeing Continued Growth and Value Creation also published in businesswire.com
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned